UB Paderborn / Katalog / Suche / in CDI

Survival with first-line bosentan in patients with primary pulmonary hypertension

The European respiratory journal, 2005-02, Vol.25 (2), p.244-249

2005

Volltextzugriff (PDF)

Autoimmunity and pulmonary hypertension: a perspective

The European respiratory journal, 2005-12, Vol.26 (6), p.1110-1118

2005

Volltextzugriff (PDF)

Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenol

Thorax, 2005-12, Vol.60 (12), p.1025-1030

2005

Volltextzugriff (PDF)

Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial

Annals of internal medicine, 2000-03, Vol.132 (6), p.425

2000

Volltextzugriff (PDF)

Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study

The Lancet (British edition), 2001-10, Vol.358 (9288), p.1119-1123

2001

Volltextzugriff (PDF)

Corrigendum for health‐related quality of life and hospitalizations in chronic thromboembolic pulmonary hypertension versus idiopathic pulmonary arterial hypertension: And analysis from the Pulmonary Hypertension Association Registry

Pulmonary circulation, 2022-04, Vol.12 (2), p.e12085-n/a

2022

Volltextzugriff (PDF)

Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension

The American journal of pathology, 1994-02, Vol.144 (2), p.275-285

1994

Volltextzugriff (PDF)

Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium

The Journal of clinical investigation, 1997-11, Vol.100 (9), p.2315-2324

1997

Volltextzugriff (PDF)

Hyperuricemia in Severe Pulmonary Hypertension

Chest, 2000-01, Vol.117 (1), p.19-24

2000

Volltextzugriff (PDF)

Bosentan Therapy for Pulmonary Arterial Hypertension

The New England journal of medicine, 2002-03, Vol.346 (12), p.896-903

2002

Volltextzugriff (PDF)

Primary pulmonary hypertension, Castleman's disease and human herpesvirus-8

The European respiratory journal, 2003-09, Vol.22 (3), p.403-407

2003

Volltextzugriff (PDF)

Coagulation and Fibrinolytic Profiles in Patients With Severe Pulmonary Hypertension

Chest, 1996-09, Vol.110 (3), p.710-717

1996

Volltextzugriff (PDF)

The Pressure-Overloaded Right Ventricle in Pulmonary Hypertension

Chest, 1998-07, Vol.114 (1), p.101S-106S

1998

Volltextzugriff (PDF)

A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension

The New England journal of medicine, 1996-02, Vol.334 (5), p.296-301

1996

Volltextzugriff (PDF)

Pulmonary capillaritis : A possible histologic form of acute pulmonary allograft rejection

The Journal of heart and lung transplantation, 1998-04, Vol.17 (4), p.415-422

1998

Volltextzugriff (PDF)

Management of pulmonary hypertension

SAMJ: South African Medical Journal, 2015-06, Vol.105 (6), p.437-439

2015

Volltextzugriff (PDF)

Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension

The New England journal of medicine, 2015-08, Vol.373 (9), p.834-844

2015

Volltextzugriff (PDF)

Genetic Risk Factors for Portopulmonary Hypertension in Patients with Advanced Liver Disease

American journal of respiratory and critical care medicine, 2009-05, Vol.179 (9), p.835-842

2009

Volltextzugriff (PDF)

CLINICAL TRIALS IN PULMONARY HYPERTENSION

Annual review of medicine, 1997-01, Vol.48 (1), p.399-408

Badesch, MD, David B

1997

Volltextzugriff (PDF)

Independent Ventilation and ECMO for Severe Unilateral Pulmonary Edema After SLT for Primary Pulmonary Hypertension

Chest, 1995-06, Vol.107 (6), p.1766-1770

1995

Volltextzugriff (PDF)

Hypothyroidism and primary pulmonary hypertension: an autoimmune pathogenetic link?

Annals of internal medicine, 1993-07, Vol.119 (1), p.44

1993

Volltextzugriff (PDF)

Colon Perforation After Lung Transplantation

The Annals of thoracic surgery, 1996-09, Vol.62 (3), p.839-843

1996

Volltextzugriff (PDF)

Ambrisentan for the Treatment of Pulmonary Arterial Hypertension : Results of the Ambrisentan in Pulmonary Arterial Hypertension, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy (ARIES) Study 1 and 2

Circulation (New York, N.Y.), 2008-06, Vol.117 (23), p.3010-3019

2008

Volltextzugriff (PDF)

Definitions and Diagnosis of Pulmonary Hypertension

Journal of the American College of Cardiology, 2013-12, Vol.62 (25), p.D42-D50

2013

Volltextzugriff (PDF)

An Evaluation of Long-term Survival From Time of Diagnosis in Pulmonary Arterial Hypertension From the REVEAL Registry

Chest, 2012-08, Vol.142 (2), p.448-456

2012

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Survival with first-line bosentan in patients with primary pulmonary hypertension

Autoimmunity and pulmonary hypertension: a perspective

Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenol

Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial

Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study

Corrigendum for health‐related quality of life and hospitalizations in chronic thromboembolic pulmonary hypertension versus idiopathic pulmonary arterial hypertension: And analysis from the Pulmonary Hypertension Association Registry

Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension

Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium

Hyperuricemia in Severe Pulmonary Hypertension

Bosentan Therapy for Pulmonary Arterial Hypertension

Primary pulmonary hypertension, Castleman's disease and human herpesvirus-8

Coagulation and Fibrinolytic Profiles in Patients With Severe Pulmonary Hypertension

The Pressure-Overloaded Right Ventricle in Pulmonary Hypertension

A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension

Pulmonary capillaritis : A possible histologic form of acute pulmonary allograft rejection

Management of pulmonary hypertension

Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension

Genetic Risk Factors for Portopulmonary Hypertension in Patients with Advanced Liver Disease

CLINICAL TRIALS IN PULMONARY HYPERTENSION

Independent Ventilation and ECMO for Severe Unilateral Pulmonary Edema After SLT for Primary Pulmonary Hypertension

Hypothyroidism and primary pulmonary hypertension: an autoimmune pathogenetic link?

Colon Perforation After Lung Transplantation

Ambrisentan for the Treatment of Pulmonary Arterial Hypertension : Results of the Ambrisentan in Pulmonary Arterial Hypertension, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy (ARIES) Study 1 and 2

Definitions and Diagnosis of Pulmonary Hypertension

An Evaluation of Long-term Survival From Time of Diagnosis in Pulmonary Arterial Hypertension From the REVEAL Registry

Suchergebnisse filtern